Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Teva UK Enters Erectile Dysfunction Category With First Ever Rx-To-OTC Switch

Liberize Launch A Landmark For Teva; Dedicated Website Launched

Executive Summary

Teva UK's first Rx-to-OTC switch is a UK Viagra Connect sildenafil competitor under the Liberize brand. Priced around 25% lower than the market leader, Teva's new brand must also compete with Perrigo's white label and Dr Reddy's Almus branded alternatives within the country's growing erectile dysfunction category. 

You may also be interested in...



Stada's Nature's Aid Launches Sustainable Supplements In UK, Frustrated At CBD Delays

HBW Insight catches up with Nature's Aid managing director Chris Morrey to talk about the firm's new sustainable dietary supplment range, Wild Earth, as well as the challenges posed by the UK's new regulstory regime for CBD novel foods. 

Over The Counter 7 December 2021: Addressing The UK's Post-Pandemic Sleep Crisis, With Perrigo VP Neil Lister

Nearly three-quarters of UK adults suffer from sleep problems, yet the majority of them do not seek help. In this episode, HBW Insight speaks to Perrigo VP and PAGB president Neil Lister about what consumer healthcare companies can do to help sleep-deprived British consumers. We talk about Perrigo's new State of the Market Report on Sleep, and how adjacencies in the OTC sleep category offer opportunities for self-care product innovation.

Why GSK Is Backing Community Pharmacy – Q&A With VP Tess Player

As a soon-to-be standalone global consumer healthcare company, the role of pharmacy is even more vital for GSK Consumer Healthcare, says vice president Tess Player, as the firm publishes its Standing with Pharmacists in the Age of Self-Care report. 

Topics

UsernamePublicRestriction

Register

GB151363

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel